VIVLODEX (nda207233)- (5MG,10MG)

Generic Name	MELOXICAM	Innovator	ICEUTICA OPERATIONS
Dosage	5MG,10MG
ParaIV Filing	Yes	505(b)2 Filing	Yes
Last Patent Expiry	2035-Mar-31	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2018-Oct-22
GAIN Expiry	None	Drug Complexity	No
Indication	VIVLODEX is a non-steroidal anti-inflammatory drug indicated for management of osteoarthritis (OA) pain.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
2	0	2

Other Developers

Total Other Developers	2

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
5MG	**	**	-	-	2
10MG	**	**	-	-	2

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	2

Manufacturing Details of VIVLODEX